1. Home
  2. TRVG vs OABI Comparison

TRVG vs OABI Comparison

Compare TRVG & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.78

Market Cap

211.2M

Sector

Technology

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.77

Market Cap

253.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
OABI
Founded
2005
2012
Country
Germany
United States
Employees
N/A
114
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.2M
253.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TRVG
OABI
Price
$2.78
$1.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$4.09
$6.67
AVG Volume (30 Days)
31.6K
258.6K
Earning Date
04-28-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.59
$52.42
Revenue Next Year
$8.42
$64.69
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$1.22
52 Week High
$5.83
$2.57

Technical Indicators

Market Signals
Indicator
TRVG
OABI
Relative Strength Index (RSI) 33.58 45.49
Support Level N/A $1.71
Resistance Level $3.26 $1.89
Average True Range (ATR) 0.06 0.12
MACD -0.02 -0.01
Stochastic Oscillator 0.00 21.62

Price Performance

Historical Comparison
TRVG
OABI

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: